Salute e Benessere

LILYSILK Launches 2025 Black Friday Sale, Celebrating Elegance and Gratitude…

The Worry-Free Wool Skirt redefines woolwear with machine-washable practicality. Designed to flatter all body types, its breathable stretch knit and fluid silhouette offer comfort without compromise and are perfect for office wear or casual elegance. TheWorry-Free Wool Skirtredefines woolwear with machine-washable practicality. Designed to flatter all body types, its breathable stretch knit and fluid silhouette offer comfort without compromise and are perfect for office wear or casual...
PR Newswire
28/10/2025

Script Runner and Uber Direct Partner to Bring Prescription Delivery to Canada

"In rural Alberta, delivery workforce shortages are a constant challenge for pharmacies," said Fayaz Rajabali, franchise owner of three pharmacies and past President of the Alberta College of Pharmacy. "By ensuring it's done properly and within the right regulatory framework, Script Runner's innovative approach with Uber helps us deliver more prescriptions in fewer trips. That means saving time, lowering costs, and ensuring patients receive their medications quickly and reliably…
PR Newswire
28/10/2025

Novartis completes acquisition of Tourmaline Bio

Basel, October 28, 2025- Novartis today announced that it has successfully completed its acquisition of Tourmaline Bio, Inc. (“Tourmaline”). With the completion of the acquisition, shares of common stock, par value $0.0001 per share (the “Shares”), of Tourmaline, have ceased trading on the Nasdaq Stock Market LLC and Tourmaline is now an indirect wholly owned subsidiary of Novartis. “The acquisition of Tourmaline Bio aligns with our strategy to deepen expertise in areas where Novartis can...
Nasdaq GlobeNewswire
28/10/2025

CeraVe Supports Global Skin Health Leaders to Deliver Care to Underserved…

World Skin Health Day is led by the International League of Dermatological Societies (ILDS) and the International Society of Dermatology (ISD). Taking place on 8 July each year, it delivers education on the significance of skin health and encourages discussions and actions that contribute toward improving skin health around the world. As the day's official corporate partner for the second year, CeraVe worked with the ILDS and ISD to build on the achievements of 2024, activating in 9 countries…
PR Newswire
28/10/2025

ALTIUS AND SYD LIFE AI ANNOUNCE $1BN PARTNERSHIP TO TRANSFORM U.S. HEALTHCARE…

Their agreement positions Altius as the exclusive U.S. provider of Syd Life AI's preventive health and life quality technologies, which are already deployed across 26 countries, enabling American employers and the U.S. healthcare system to shift to preventive care. Their agreement positions Altius as the exclusive U.S. provider of Syd Life AI's preventive health and life quality technologies, which are already deployed across 26 countries, enabling American employers and the U.S. healthcare...
PR Newswire
28/10/2025

MAXIMA GRUPĖ redeemed EUR 240 million bond emission

On October 27, MAXIMA GRUPĖ, UAB (hereinafter – MAXIMA GRUPĖ) exercised its early redemption right and redeemed all bonds with a nominal value of EUR 240 million from bondholders. On July 12, 2022, a five-year bond issue with a nominal value of EUR 240 million and a fixed annual interest rate of 6.25% (6.50% annual yield) was distributed. Following the decision to redeem the bonds early, the actual annual yield on the bonds amounted to 8.40%. As previously announced, MAXIMA GRUPĖ has...
Nasdaq GlobeNewswire
28/10/2025

Ajinomoto Bio-Pharma Services and Olon S.p.A. Form Strategic Partnership to…

This collaboration combines Aji Bio-Pharma's expertise in microbial strain and process development with Olon's large-scale GMP manufacturing expertise utilizing fermenters with a capacity of over 100,000 liters. The partnership will accelerate productive and sustainable manufacturing of high-demand proteins and peptides such as GLP-1 analogs which play a critical role in treating obesity and Type II diabetes. This collaboration combines Aji Bio-Pharma's expertise in microbial strain and…
PR Newswire
28/10/2025

Novo Nordisk to present new Wegovy® (semaglutide 2.4 mg) data at the 2025…

The research to be presented at The Liver Meeting® 2025 reflects Novo Nordisk's leadership in advancing the understanding of optimal screening, diagnosis, and management of MASH and other serious chronic conditions. The research to be presented at The Liver Meeting ®2025 reflects Novo Nordisk's leadership in advancing the understanding of optimal screening, diagnosis, and management of MASH and other serious chronic conditions. Summary of presentationsAccepted data at The Liver Meeting...
PR Newswire
28/10/2025

BioNTech to Host Innovation Series R&D Day on November 11, 2025

MAINZ, Germany, October 28 , 2025 (GLOBE NEWSWIRE)-- BioNTech SE(Nasdaq: BNTX, “BioNTech” or “the Company”), will host an edition of the Company’s Innovation Series R&D Day at 09:00 a.m. Eastern Standard Time (3:00 p.m. CET) on Tuesday, November 11, 2025 in New York City, U.S. On the day, members of BioNTech’s leadership team will provide an overview of the Company’s strategy and clinical progress across its pipeline.Investors, analysts and the interested public are invited to...
Nasdaq GlobeNewswire
28/10/2025

BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES

On September 15, 2025, the Company issued Debentures for an aggregate principal amount of $335,670 convertible into common shares in the capital of the Company ("Shares") at any time, at the option of the holders thereof, at the closing price of the Shares on the Canadian Securities Exchange (the "CSE") on the day notice of conversion is received by the Company, subject to the pricing requirements in the policies of the CSE. The Debentures bear interest at a rate of 10% per…
PR Newswire
28/10/2025

Alkermes plc Reports Third Quarter 2025 Financial Results

— Company Raises 2025 Financial Expectations — — Company Raises 2025 Financial Expectations — DUBLIN , Oct. 28, 2025 /PRNewswire/ --Alkermes plc(Nasdaq: ALKS) today reported financial results for the third quarter of 2025. "Alkermes delivered another successful quarter, achieving strong revenue growth and robust profitability, fueled by focused execution and underlying demand across our commercial portfolio. We ended the quarter in a strong financial position and have...
PR Newswire
28/10/2025

Amphista Therapeutics to showcase how its Targeted Glue™ technology is expanding…

Presentation will showcase the novel mechanisms of degradation of Amphista's Targeted Glues™, which recruit diverse E3 ligases, including DCAF16 and FBXO22, expanding the diversity and opportunity for TPD medicines.The Company’s Eclipsys® platform, founded on a multidisciplinary team employing leading-edge technologies, is delivering breakthrough accomplishments across it’s BRD9, SMARCA2 and TEAD programs.Cambridge, UK, 28 October, 2025– Amphista Therapeutics (“the Company” or...
Nasdaq GlobeNewswire
28/10/2025

AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical…

AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board Brings substantial expertise in development of first-in-class disease-modifying therapies in dementia across multiple novel modalitiesIncludes immunotherapies and small molecule drugs targeting intracellular proteinopathiesLeadership in groundbreaking early-stage clinical trials reinforces Company’s competencies Lausanne, Switzerland, October 28, 2025 --AC Immune SA (NASDAQ: ACIU), a...
Nasdaq GlobeNewswire
28/10/2025

Upgrade of guidance

ANNOUNCEMENT NO. 295 28 October 2025Upgrade of guidance ChemoMetec experiences an increased interest in its technology, not the least the XcytoMatic platform, and consequently expects a positive trend in revenue and profit particularly in the last part of the financial year 2025/26.Consequently, revenue in the financial year 2025/26 is now expected to be DKK 565-580 million against the most recently announced DKK 545-565 million, while EBITDA is expected to be in the range of...
Nasdaq GlobeNewswire
28/10/2025

Orion Group Interim Report January–September 2025

ORION CORPORATIONINTERIM REPORT 1–9/202528 OCTOBER 2025 at 12:00 EETOrion Group Interim Report January–September 2025July–September 2025 HighlightsNet sales totalled EUR 423.2 (July–September 2024: 471.3) million Operating profit was EUR 121.0 (202.0) millionNet sales and operating profit of the comparison period include EUR 130 million of major milestone paymentsBasic earnings per share were EUR 0.68 (1.14)Cash flow from operating activities per share was EUR 0.55 (0...
Nasdaq GlobeNewswire
28/10/2025

Clinical Trials Market Growing at 6.51% CAGR to 2030 Driven by Hybrid and…

Rising Adoption of Decentralized and Hybrid Trial Models Rising Adoption of Decentralized and Hybrid Trial Models Decentralized and hybrid trial models are transforming clinical research by reducing patient travel, improving retention, and expanding access through telehealth, local labs, and at-home monitoring. With growing acceptance among participants and clear regulatory guidance from the FDA, sponsors are focusing on technology readiness, data integrity, and cybersecurity as key...
PR Newswire
28/10/2025

WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic…

This partnership brings together WuXi AppTec's decades of experience as a trusted partner to the global biopharmaceutical industry with NEOM's commitment to fostering innovation and building a future-focused ecosystem. The MoU offers a compelling opportunity to extend WuXi AppTec's integrated capabilities into a market with ambitious national biotechnology goals. It also capitalizes on NEOM's visionary approach to sustainability, innovation, and talent development. This partnership brings...
PR Newswire
28/10/2025

LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS…

Phase 2b (LT3001-202, China): Efficacy and Safety OverviewThe China Phase 2b study met its primary endpoint of safety. No treatment-related symptomatic intracranial hemorrhage (sICH) was observed. Across all treatment groups, LT3001 demonstrated a consistent trend of functional improvement compared with placebo. At day 90, patients receiving LT3001 achieved a 7.3% higher rate of functional independence (mRS 0–2). Phase2b(LT3001-202,China ): Efficacy and Safety OverviewThe China Phase...
PR Newswire
28/10/2025

Xinhua Silk Road: Innovation, tradition deeply integrated on TCM trade fair in…

The fair also featured a one-stop match-making platform to help find partners for the TCM companies to put their latest innovative medicines and technologies into mass production. Ten cooperative agreements on TCM industrial projects covering medical equipment and new medicine development were signed on the fair. The fair also featured a one-stop match-making platform to help find partners for the TCM companies to put their latest innovative medicines and technologies into mass production...
PR Newswire
28/10/2025

ViCentra Strengthens Leadership Team to Accelerate Growth

"These are transformative additions to our leadership team," said Tom Arnold, Chief Executive Officer of ViCentra. "Karen brings an exceptional track record of scaling category-defining diabetes businesses across Europe through both direct sales as well as distributors. Jay adds deep strategic expertise in partnerships, reimbursement, and commercial execution. With their leadership, ViCentra is well-positioned to bring the Kaleido experience to more people living with…
PR Newswire
28/10/2025

Experience the Future of Clean: CCE 2026 Invites Global Professionals to…

Building on last year's success, CCE 2026 will feature the returning zones for Restroom Supplies, Smart Cleaning, and Environmental Sanitation, plus three new additions: Property Management, High-pressure Cleaning, and Laundry Products Zones. The Smart Cleaning Zone highlights one of the industry's fastest-growing sectors. The global commercial cleaning robot market is projected to reach USD 1.56 billion by 2031, growing at a 20.2% CAGR, driven by labor shortages and demand for smarter…
PR Newswire
28/10/2025

DJI's First All-in-One Robot Vacuum ROMO: Flagship Technology Flies into the…

Millimeter-Level Obstacle Sensing That Even Dodges Playing Cards Millimeter-Level Obstacle Sensing That Even Dodges Playing Cards ROMO features an advanced obstacle sensing system with high-performance dual fisheye vision sensors and wide-angle dual-transmitter solid-state LiDARs, leveraging technology derived from DJI's flagship drones. Coupled with machine learning this enables ROMO to recognize and avoid household obstacles such as 2mm thick charging cables or even playing cards...
PR Newswire
28/10/2025

Kanazawa University Research: Scanning nanoprobe microscope reveals the hidden…

Changes in nuclear mechanics are a hallmark of cancer and can indicate malignant transformation. Traditionally, nuclear elasticity has been studied using atomic force microscopy (AFM) probes pressing on the cell membrane or by aspirating isolated nuclei. Both methods suffer from limitations: they are influenced by surrounding cellular structures or fail to capture intact nuclear states. The new NE-AFM method developed by Takehiko Ichikawa and colleagues at Kanazawa University overcomes these…
PR Newswire
28/10/2025

Bavarian Nordic Provides Further Support to Mpox Outbreak in Africa through…

COPENHAGEN, Denmark, October 28, 2025– Bavarian Nordic announced today a donation of mpox vaccines to Africa CDC to support the response to the ongoing mpox outbreak in Africa.The donation of 110,000 doses of the vaccine has been allocated to Uganda in coordination with the key partners involved in the mpox Access and Allocation Mechanism (AAM), significantly increasing the availability of vaccines in the country, which has reported the second-highest number of cases of mpox in Africa in...
Nasdaq GlobeNewswire
28/10/2025
Altri  Comunicati